In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of anti-TNF therapy.
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid ...
There should not be a controversy over anabolic steroid use in athletics -- non-medical use of anabolic steroids is illegal and banned by most, if not all, major sports organizations. Still ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results